Retrospective analysis of real-world data to determine clinical outcomes of patients with advanced non-small cell lung cancer following cell-free circulating tumor DNA genomic profiling Published August 2020 Citation Madison, RW, Schrock, AB, Castellanos, EH, Gregg, JP, Snider, J, Ali, SM, Miller, VA, Singal, G, Alexander, BM, Venstrom, JM, Chung, JH. . Lung Cancer. . https://doi.org/10.1016/j.lungcan.2020.07.033 Authors:Madison, RW, Schrock, AB, Castellanos, EH, Gregg, JP, Snider, J, Ali, SM, Miller, VA, Singal, G, Alexander, BM, Venstrom, JM, Chung, JH Sources:Lung Cancer Share Posted inPublicationsTreatment patternsNon-small cell lung cancer More publicationsWorld Conference on Lung CancerAugust 2025Evolving treatment patterns in early-stage non-small cell lung cancer in the USGray J E, Thoele K, Gilligan A M, et al.Publication summaryPublicationsTreatment patternsNon-small cell lung cancerWorld Conference on Lung CancerAugust 2025Real-world biomarker testing and treatment initiation in patients with resected early-stage NSCLC (eNSCLC) in the US and UKRinaldi C, Halloran S, Pittel H, et al.Publication summaryPublicationsTreatment patternsNon-small cell lung cancerWorld Conference on Lung CancerAugust 2025Real-world treatment patterns and clinical outcomes in patients with metastatic neuroendocrine neoplasms of the lung (NEN-L)Zu K, Vaidya R, Cho-Phan C, Hu H.Publication summaryPublicationsTreatment patternsNon-small cell lung cancer